Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Myelodysplastic Syndromes
.
Show all posts
Showing posts with label
Myelodysplastic Syndromes
.
Show all posts
Thursday, June 11, 2026
Ofirnoflast (HT-6184) Receives Orphan Drug Designation from U.S. FDA for Myelodysplastic Syndromes
›
Halia Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering therapies that target the root causes of inflammation-driven...
›
Home
View web version
